Niranjan Awasthi

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Combination Therapy

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

Journal of cellular and molecular medicine

Cancer biology & therapy

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Niranjan Awasthi, Lily Darman, Margaret A Schwarz, Roderich E Schwarz
Telotristat ethyl, a tryptophan hydroxylase inhibitor, enhances antitumor efficacy of standard chemotherapy in preclinical cholangiocarcinoma models. Journal of cellular and molecular medicine 28 (17) (2024)
Niranjan Awasthi, Margaret A Schwarz, Changhua Zhang, Stephan G Klinz, Florence Meyer-Losic, Benjamin Beaufils, Arunthathi Thiagalingam, Roderich E Schwarz
Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy. Molecular cancer therapeutics 21 (7) (2022)
Meghan Grojean, Margaret A Schwarz, Johann R Schwarz, Sazzad Hassan, Urs von Holzen, Changhua Zhang, Roderich E Schwarz, Niranjan Awasthi
Targeted dual inhibition of c-Met/VEGFR2 signalling by foretinib improves antitumour effects of nanoparticle paclitaxel in gastric cancer models. Journal of cellular and molecular medicine 25 (11) (2021)
Kate Crawford, Erin Bontrager, Margaret A Schwarz, Apurva Chaturvedi, Daniel D Lee, Hassan Md Sazzad, Urs von Holzen, Changhua Zhang, Roderich E Schwarz, Niranjan Awasthi
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models. Cancer biology & therapy (2021)
Niranjan Awasthi, Amanda J Mikels-Vigdal, Erin Stefanutti, Margaret A Schwarz, Sheena Monahan, Victoria Smith, Roderich E Schwarz
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer. Journal of cellular and molecular medicine 23 (6) (2019)